Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Weekly Deals, The Week Ending March 2, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Seven Hills Capital, LLC VersiCare Group N/A eHealth Acquirer Target Price Revint Solutions Naveos N/A Melissa Data IO Informatics, Inc. N/A R1 RCM Inc. Intermedix Corporation $460 million The... Read More »
Health Care M&A Weekly Deals, The Week Ending February 23, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Merck Viralytics Limited $394 million BenevolentAI Cambridge Research Campus N/A Kite Pharma License to zinc finger nuclease technology $150 million eHealth Acquirer Target Price TractManager, Inc.... Read More »
Health Care M&A Weekly Deals, The Week Ending February 16, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Bioverativ Inc. License to lentiviral vectors $5 million Oncologie, Inc. Exclusive license to lefitolimod $369 million Lee’s Pharmaceutical Limited Exclusive rights to GCC-4401C N/A Bristol-Myers... Read More »
